SCHEMBL7863167

SCHEMBL7863167

CCCCCCCCCCCCc1ccc(S(=O)(=O)N2CCCC(CO)C2)cc1

nearest known ligand 0.63

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.63
CYP2C19 P33261 1/20 0.63
SPHK2 Q9NRA0 5/20 0.53
SPHK1 Q9NYA1 5/20 0.53
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
MMP1 P03956 1/20 0.46
MMP3 P08254 1/20 0.46
MMP7 P09237 1/20 0.46
MMP13 P45452 1/20 0.46
KMT2A Q03164 1/20 0.45
KCNH2 Q12809 1/20 0.44
HRH3 Q9Y5N1 1/20 0.44
ALDH1A1 P00352 1/20 0.44
TP53 P04637 1/20 0.44
CYP19A1 P11511 1/20 0.43
LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8710392 0.91 CYP3A4 (0.50) CYP3A4CYP2C19SPHK2SPHK1NPC1
SCHEMBL12189229 0.86 CYP2C19 (0.72) CYP3A4CYP2C19NPC1RAB9ASMN1; SMN2
SCHEMBL7856365 0.85 NPSR1 (0.56) SPHK2SPHK1KMT2AKCNH2HRH3
SCHEMBL12587132 0.80 CYP3A4 (0.76) CYP3A4CYP2C19NPC1RAB9ASMN1; SMN2
SCHEMBL7861726 0.80 L3MBTL1 (0.63) SMN1; SMN2MMP1MMP3MMP7MMP13
SCHEMBL10726957 0.79 SMN1; SMN2 (0.58) CYP3A4NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL5245752 0.78 MAPT (0.65) CYP2C19NPC1RAB9ASMN1; SMN2KMT2A
SCHEMBL5254341 0.78 CYP3A4 (0.76) CYP3A4CYP2C19SMN1; SMN2KMT2AALDH1A1
SCHEMBL19265264 0.78 CYP3A4 (0.76) CYP3A4CYP2C19RAB9ASMN1; SMN2KMT2A
SCHEMBL4741603 0.78 CYP2C19 (0.75) CYP3A4CYP2C19SMN1; SMN2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0861210-B1 USE OF SULFONAMIDES FOR CONTROLLING BIOFOULING BUCKMAN LABOR INC (US) 2001-12-12 EP claimed
EP-0861210-A1 METHODS AND COMPOSITIONS FOR CONTROLLING BIOFOULING USING SULFONAMIDES BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) 1998-09-02 EP claimed
WO-1997011913-A1 METHODS AND COMPOSITIONS FOR CONTROLLING BIOFOULING USING SULFONAMIDES BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) 1997-04-03 WO claimed
EP-0861210-B1 USE OF SULFONAMIDES FOR CONTROLLING BIOFOULING BUCKMAN LABOR INC (US) 2001-12-12 EP disclosed